Key points are not available for this paper at this time.
Liver biopsy rates are increasing likely owing to the changing epidemiology and management of common liver diseases. The similarity of the complication rate in our population-based study with estimates from specialized centres supports the safety of this important procedure.
Myers et al. (Thu,) studied this question.